DRESS/DiHS syndrome induced by Propylthiouracil: a case report
Open Access
- 23 January 2023
- journal article
- case report
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 23 (1) , 1-6
Abstract
Background: Drug reaction with eosinophilia and systemic symptoms (DRESS), also known as Drug-induced hypersensitivity syndrome (DiHS), is a severe adverse drug reaction. Propylthiouracil, a member of thiouracils group, is widely used in medical treatment of hyperthyroidism. Propylthiouracil is associated with multiple adverse effects such as rash, agranulocytosis hepatitis and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, but rarely triggers DRESS/DiHS syndrome. Here, we describe a severe case of propylthiouracil-induced DRESS/DiHS syndrome. Case presentation: A 38-year-old female was treated with methimazole for hyperthyroidism at first. 4 weeks later, the patient developed elevated liver transaminase so methimazole was stopped. After liver function improved in 2 weeks, medication was switched to propylthiouracil therapy. The patient subsequently developed nausea and rash followed by a high fever, acute toxic hepatitis and multiple organ dysfunction (liver, lung and heart), which lasted for 1 month after propylthiouracil was started. According to the diagnostic criteria, the patient was diagnosed of DRESS/DiHS syndrome which was induced by propylthiouracil. As a result, propylthiouracil was immediately withdrawn. And patient was then treated with adalimumab, systematic corticosteroids and plasmapheresis in sequence. Symptoms were finally resolved 4 weeks later. Conclusions: Propylthiouracil is a rare cause of the DRESS/DiHS syndrome, which typically consists of severe dermatitis and various degrees of internal organ involvement. We want to emphasize through this severe case that DRESS/DiHS syndrome should be promptly recognized to hasten recovery.Keywords
Funding Information
- National Natural Science Foundation of China (81900714)
- Suzhou Municipal Science and Technology Bureau (SYSD126)
This publication has 34 references indexed in Scilit:
- Therapeutic management of DRESS: A retrospective study of 38 casesJournal of the American Academy of Dermatology, 2015
- Sequelae in 145 patients with drug‐induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: Survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR)The Journal of Dermatology, 2015
- Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR studyBritish Journal of Dermatology, 2013
- DRESS syndromeJournal of the American Academy of Dermatology, 2013
- Human Herpesvirus 6 Reactivation in Drug-induced Hypersensitivity Syndrome and DRESS Validation ScoreThe American Journal of Medicine, 2012
- Poor Benefit/Risk Balance of Intravenous Immunoglobulins in DRESSArchives of Dermatology, 2012
- Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): A Multiorgan Antiviral T Cell ResponseScience Translational Medicine, 2010
- Propylthiouracil‐induced DRESS syndrome confirmed by a positive patch testAllergy, 2010
- Propylthiouracil Hypersensitivity with Circumstantial Evidence for Drug-Induced Reversible Sensorineural Deafness: A Case ReportHormone Research, 1991
- SODIUM DIPHENYL HYDANTOINATE IN THE TREATMENT OF CONVULSIVE DISORDERSJAMA, 1938